Latest "Valeant Surges Post Reassessment" News Stories

05:28 EDT 19th September 2018 | BioPortfolio

Here are the most relevant search results for "Valeant Surges Post Reassessment" found in our extensive news archives from over 250 global news sources.

More Information about Valeant Surges Post Reassessment on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Valeant Surges Post Reassessment for you to read. Along with our medical data and news we also list Valeant Surges Post Reassessment Clinical Trials, which are updated daily. BioPortfolio also has a large database of Valeant Surges Post Reassessment Companies for you to search.

Showing "Valeant Surges Post Reassessment" News Articles 1–25 of 6,300+

Wednesday 19th September 2018

Diamond and Thermo Fisher to provide cryo-EM to pharma sector

The UK’s centralised state-of-the-art cyro-EM facility, the electron Bio-Imaging Centre (eBIC), has been officially opened at Diamond Light Source, the...Read More... The post Diamond and Thermo Fisher to provide cryo-EM to pharma sector appeared first on Pharmaceutical Technology.

Tuesday 18th September 2018

Analysis finds HPV vaccine safe

(Wiley) Infection with human papillomavirus (HPV) can cause certain cancers in women and men, but HPV vaccines are highly effective in preventing infection with oncogenic HPV types. A new British Journal of Clinical Pharmacology review of post-licensure data did not identify any new or unexpected safety concerns of the bivalent HPV vaccine.

Air pollution may be linked to heightened dementia risk

Associations found not explained by known influential factors Air pollution may be linked to a heightened risk of developing dementia, finds a London-based observational study, published in the online journal BMJ Open. The associations found couldn’t be explained by factors known to influence the risks of developing the condition, say the researchers. Air pollution is now [...] Read More... The...

Sugar content of most supermarket yogurts well above recommended threshold

Organic products, perceived as healthier options, among some of the worst offenders The sugar content of most types of yogurt is well above the recommended threshold, reveals an analysis of the nutrient content of available UK supermarket products, published in the online journal BMJ Open. And organic varieties, often viewed as healthier options, contain some of [...] Read More... The post Sugar ...

Cancer Genetics Merges With NovellusDx

Two companies with similar oncology goals, Cancer Genetics and NovellusDx, have signed a definitive merger agreement, announced Tuesday. The post Cancer Genetics Merges With NovellusDx appeared first on Investing News Network.

Inovio Develops Vaccine for Deadly Flu Virus

Inovio Pharmaceuticals announced the research from its SynCon approach on Monday, which uses a collection of DNA antigens to protect antibody responses against the flu viruses. This idea has already proven itself in a preclinical study with mice. The post Inovio Develops Vaccine for Deadly Flu Virus appeared first on Investing News Network.

John McCain: A Healthcare Legacy

We don’t normally think of Senator John McCain as a healthcare leader, and yet he played a significant role over the years in various policy matters. CareCentrix CEO, John Driscoll and I pay tribute in a short edition of #CareTalk. The post John McCain: A Healthcare Legacy appeared first on Health Business Group.

Cancer Genetics and NovellusDx Sign Definitive Agreement to Merge

Cancer Genetics (Nasdaq:CGIX), a leader in enabling precision medicine for immuno-oncology and genomic medicine through molecular markers and diagnostics, and NovellusDx, a leader in functional genomics, today announced the signing of a definitive agreement under which NovellusDx will merge with a newly formed Israeli subsidiary of Cancer Genetics and shareholders of NovellusDx will receive stock ...

Hemispherx to Distribute Second Lot of Ampligen for use in Multiple Indications in Argentina, the United States and Europe

Hemispherx Biopharma (NYSE:HEB) announced today regulatory inspection and clearance for distribution of the Company’s second commercial scale lot of Ampligen (rintatolimod), which is slated for multiple uses including product launch in Argentina, where Ampligen is approved for the treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), ME/CFS expanded access program (EAP) in t...

Nemaura Signs Letter of Intent for SugarBEAT Commercial Launch in Qatar

Nemaura Medical (NASDAQ:NMRD), a medical technology company developing sugarBEAT® as a non-invasive affordable and flexible Continuous Glucose Monitor (CGM) for use by persons with diabetes and pre-diabetics, today announced that it has signed a non-binding letter of intent for an exclusive licensing agreement with Al-Danah Medical Co for the commercial launch of sugarBEAT® in Qatar. As …...

Osiris Therapeutics Announces GrafixPL PRIME Launches October 1, 2018

Osiris Therapeutics (NASDAQ:OSIR), a regenerative medicine company focused on developing and marketing products for wound care, orthopedics, and sports medicine, announces that GrafixPL PRIME™, a human placental membrane that can be stored at ambient temperatures, launches for sale on October 1, 2018. As quoted in the press release: The structural matrix, growth factors, and cell viability R...

Global Cognition Supplements Market 2018-2022 to Post a CAGR of 14% CAGR Over the Next Four Years | Technavio

The global cognition supplements market is expected to post a CAGR of close to 14% during the period 2018-2022, according to the latest market research report by Technavio. This press release features multimedia. View the full release here:

Cardiol Therapeutics Announces Filing of Preliminary Prospectus

Cardiol Therapeutics Inc. ("Cardiol" or the "Company"), a biotechnology company specializing in the research and commercial development of novel drug therapies utilizing proprietary drug-delivery systems, is pleased to announce that it has filed a preliminary prospectus with the securities regulatory authorities in each of the provinces of Canada, except Quebec, in connection with a proposed initi...

Severely obese boy, 13, collapses and dies at 16 stone – Metro

MetroSeverely obese boy, 13, collapses and dies at 16 stoneMetroA 13-year-old has collapsed and died due to being severely obese at 16 stone. The teenager is believed to be the youngest victim of the frightening rise in youngsters who are overweight. A post mortem by a pathologist said he could find no other reason ...and more

Corbus Pharmaceuticals Holdings, Inc. (CRBP) Receives Orphan Designation for Lenabasum

Corbus Pharmaceuticals Receives Orphan Designation for Lenabasum for the Treatment of Dermatomyositis in the European Union Corbus Pharmaceuticals Holdings, Inc. (CRBP) (“Corbus” or the “Company”), a Phase 3 clinical-stage pharmaceutical company focused on the development and commercialization of novel therapeutics to treat rare, chronic and serious inflammatory and fibrotic diseases, anno...

Always on my mind Professor Giovanna Mallucci’s latest paper almost broke the internet: her research has the potential to transform the lives of patients living with Alzheimer’s disease.

All Cambridge Neuroscience’s work is, of course, worthy of attention. Yet it is probably safe to say that few pieces of research require an addendum acknowledging the sheer level of public interest they spark. “Professor Mallucci is very thankful for your interest and support,” reads the addendum to the story detailing the paper Repurposed drugs […] The post Always on my mind Professo...

Drug prices increased twice as fast during shortages

A team of researchers have found that drugs increase in price twice as fast during shortages than if there were not supply and demand imbalances... The post Drug prices increased twice as fast during shortages appeared first on European Pharmaceutical Review.

Molecular Assemblies Expands Patent Portfolio in Enzymatic DNA Synthesis

SAN DIEGO, September 18, 2018 — Molecular Assemblies, Inc. today announced the recent award of three patents, bringing the total to eight issued patents protecting the company’s proprietary enzymatic DNA synthesis technology in the United States and Europe. The three […] The post Molecular Assemblies Expands Patent Portfolio in Enzymatic DNA Synthesis appeared first on SynBioBeta.

Cockle Molecules Could Help Fight Cancer

As you eat your plate of delicious cockles, spare a thought for how their sugars might help to tackle cancer, suggest researchers from the University of Salford, UK. Testing cockle-derived sugars on cancer cells in the lab, the research group ... The post Cockle Molecules Could Help Fight Cancer appeared first on

Canntab Signs Collaboration and Profit Sharing Agreement with FSD Pharma for Production and Market of Oral Dose Delivery Platforms

Canntab Therapeutics (CSE:PILL) (the "Company" or "Canntab") is pleased to announce that it has signed a definitive collaboration and profit sharing agreement (the "Agreement) (OTC Pink: FSDDF) (FRA: 0K9) ("FSD Pharma"), which, through its wholly-owned subsidiary FV Pharma Inc., is a licensed producer pursuant to the Access to Cannabis for Medical Purposes Regulations, effective September 17, 201...

Canntab and Emblem Announce Positive Results on Testing: Proceeding to Clinical Trials

Canntab Therapeutics (CSE:PILL) ("Canntab" or the "Company"), today announced the achievement of a milestone with regards to the development of a patent-pending oral extended release formulation for cannabinoids in collaboration with Emblem Corp. (TSXV: EMC) (OTCQX: EMMBF), a licensed producer of medical cannabis under the Access to Cannabis for Medical Purposes Regulations ("ACMPR") through its...

Pfizer Reports Addl Analyses From Tafamidis Phase 3 ATTR-ACT Study

NEW YORK CITY (dpa-AFX) - Pfizer Inc. (PFE) said that additional sensitivity and post-hoc analyses from the Tafamidis Phase 3 Transthyretin Amyloid Cardiomyopathy or ATTR-ACT study provide further...

Micronizing Plastics Threaten Sea Turtle Populations

NewsIngestion of degrading ocean plastics likely poses a substantial risk to the survival of post-hatchling sea turtles.Contributed Author: 

Wolf Greenfield Named Patent Strategy & Management Firm of the Year at 2018 LMG Life Sciences Awards

Intellectual property law firm Wolf, Greenfield & Sacks, P.C. today announced that it was named the “Patent Strategy & Management Firm of the Year” at the 2018 LMG Life Sciences Awards, held at the Essex House in New York City on September 12, 2018. Now in its sixth year, the LMG Life Sciences Aw

Using Telemedicine to Combat the Opioid Epidemic

Combatting the opioid crisis is a top priority for the Trump Administration and the U.S. Department of Health and Human Services (HHS).  We are making progress. Just last week we released the 2017 National Survey on Drug Use and Health (NSDUH) data, which showed significantly more people received treatment for substance use disorder in 2017 than in 2016; this was especially true for those with he...

Quick Search


News Quicklinks